Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New gene therapy targets inherited dementia in early trial

NCT ID NCT04747431

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times

Summary

This study tests a single dose of a gene therapy called PBFT02 in 30 adults with frontotemporal dementia caused by specific gene mutations. The treatment aims to deliver a working copy of the GRN gene to the brain to help control the disease. Researchers are primarily checking safety and how the therapy affects protein levels in spinal fluid and blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRONTOTEMPORAL DEMENTIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centro Hospitalar e Universitário de Coimbra

    Coimbra, Portugal

  • Eastern Health-Box Hill Hospital

    Melbourne, Victoria, 3128, Australia

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP)

    São Paulo, Brazil

  • Hospital das Clinicas da Universidade Federal de Minas Gerais (UFMG)

    Minas Gerais, Brazil

  • Michigan Alzheimer's Disease Center

    Ann Arbor, Michigan, 48105, United States

  • Montreal Neurological Institute-Hospital

    Montreal, Quebec, H3A 2B4, Canada

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • University of Texas at Houston

    Houston, Texas, 77030, United States

  • University of Toronto, Toronto Western Hospital

    Toronto, Ontario, M5T 2S8, Canada

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.